Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer

2020350 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov identifier: NCT02715284.

Good health and well-being

Published in: JAMA Oncology

Volume 6, Issue 11, pp. 1766-1766

Field-Weighted Citation Impact: 33.90